World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
27950
World Ranking
14551
National Ranking
7364

Overview

Mary Lee Vance is affiliated with the University of Virginia in the United States. Their research mainly spans fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these, the scientist has contributed notably to Molecular Biology, Neurology, Oncology, Cancer Research, and Endocrinology, Diabetes and Metabolism.

Their work addresses several critical topics, including:

  • Cerebrovascular and genetic disorders
  • Angiogenesis and VEGF in Cancer
  • Cancer, Hypoxia, and Metabolism
  • Melanoma and MAPK Pathways
  • CAR-T cell therapy research
  • Epigenetics and DNA Methylation
  • Fibroblast Growth Factor Research

Key recent papers authored by or involving Mary Lee Vance include:

  • Vascular smooth muscle cell-specific Igf1r deficiency exacerbates the development of hypertension-induced cerebral microhemorrhages and gait defects, 2024, GeroScience
  • IGF1R deficiency in vascular smooth muscle cells impairs myogenic autoregulation and cognition in mice, 2024, Frontiers in Aging Neuroscience
  • Microvascular smooth muscle cells exhibit divergent phenotypic switching responses to platelet-derived growth factor and insulin-like growth factor 1, 2023, Microvascular Research
  • 1108P Real world (RW) sequencing outcomes with immunotherapy and targeted therapy (TT) in BRAF+ metastatic melanoma (The NOBLE study series), 2020, Annals of Oncology
  • 1111P Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series), 2020, Annals of Oncology

The scientist frequently collaborates with colleagues such as Shannon M. Conley, Marisa A. Bickel, Elizabeth C. Bullen, Eric W. Howard, and Lauren R. Miller, with multiple coauthored works reflecting sustained research partnerships.

Mary Lee Vance's publications appear regularly in venues such as Annals of Oncology, GeroScience, Frontiers in Aging Neuroscience, Microvascular Research, and SSRN Electronic Journal, showing a focus on both clinical and molecular aspects of disease processes.

Best Publications

  • Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement

    G. Arnaldi;A. Angeli;A. B. Atkinson;X. Bertagna

  • The prevalence of pituitary adenomas: a systematic review.

    Shereen Ezzat;Sylvia L. Asa M.D.;William T. Couldwell;M.P.H. Charles E. Barr M.D.

  • Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

    Mark E. Molitch;David R. Clemmons;Saul Malozowski;George R. Merriam

  • Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

    B.M.K. Biller;Ashley Barry Grossman;P.M. Stewart;Shlomo Melmed

  • Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.

    Trainer Pj;Drake Wm;Katznelson L;Freda Pu

  • Guidelines for Acromegaly Management: An Update

    S. Melmed;A. Colao;A. Barkan;Mark E Molitch

  • Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

    Aart Jan van der Lely;R Kent Hutson;Peter J Trainer;G Michael Besser

  • Pituitary incidentaloma: an endocrine society clinical practice guideline.

    Pamela U. Freda;Albert M. Beckers;Laurence Katznelson;Mark E. Molitch

  • CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

    Mark E. Molitch;David R. Clemmons;Saul Malozowski;George R. Merriam

  • Guidelines for Acromegaly Management

    S. Melmed;F. F. Casanueva;F. Cavagnini;P. Chanson

  • Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria

    J. Kreutzer;M. L. Vance;M. B. S. Lopes;E. R. Laws

  • Octreotide Treatment of Acromegaly: A Randomized, Multicenter Study

    Shereen Ezzat;Peter J. Snyder;William Francis Young;Louis D. Boyajy

  • Growth Hormone Therapy in Adults and Children

    Mary Lee Vance;Nelly Mauras

  • Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.

    John A. Jane;Robert M. Starke;Mohamed A. Elzoghby;Mohamed A. Elzoghby;Davis L. Reames

  • Safety and efficacy of long-term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients—a clinical research center study

    C B Newman;S Melmed;P J Snyder;W F Young

  • Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.

    Chirag G. Patil;Daniel M. Prevedello;Shivanand P. Lad;Mary Lee Vance

  • Octreotide as primary therapy for acromegaly

    Connie B. Newman;Shlomo Melmed;Ajax George;Drew Torigian

  • Drugs Five Years Later: Bromocriptine

    Mary Lee Vance;William S. Evans;Michael O. Thorner

  • Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

    M L Hartman;S M Pincus;M L Johnson;D H Matthews

  • Consensus statement: medical management of acromegaly

    S Melmed;F Casanueva;F Cavagnini;P Chanson

Frequent Co-Authors

Edward R. Laws
Edward R. Laws Brigham and Women's Hospital
Michael O. Thorner
Michael O. Thorner University of Virginia
Jason P. Sheehan
Jason P. Sheehan University of Virginia
Wylie Vale
Wylie Vale Salk Institute for Biological Studies
Jean Rivier
Jean Rivier Salk Institute for Biological Studies
Alan D. Rogol
Alan D. Rogol University of Virginia
John A. Jane
John A. Jane University of Virginia Health System
Anne Klibanski
Anne Klibanski Harvard University
Shlomo Melmed
Shlomo Melmed Cedars-Sinai Medical Center
Mark E. Molitch
Mark E. Molitch Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have increasingly flexible options through online degree programs. Whether you are starting your journey or looking to advance your career, online education can help you meet your goals while balancing work and personal responsibilities.

If you're considering nursing, a common concern is how much does online nursing school cost. Tuition can vary significantly depending on the institution and program, but researching affordable options can help reduce financial barriers.

For registered nurses looking to enhance their credentials, exploring the cheapest rn to bsn program offerings can be a practical step. Many of these programs are designed for working professionals and can be completed at your own pace.

Those interested in advanced practice roles might consider a phd nursing education online or pursue specialized direct entry options. Additionally, direct entry nurse practitioner programs for non-nurses online create new career avenues for those coming from different backgrounds.

Exploring these online pathways not only opens doors to new professions but also offers greater flexibility and affordability for future medical practitioners.

Best Scientists Citing Mary Lee Vance

Trending Scientists

Recently Published Articles